TY - JOUR
AU - H. E. Jones
AU - K. Kaltenbach
AU - E. Johnson
AU - C. Seashore
AU - E. Freeman
AU - E. Malloy
A1 - 
AB - This clinical case conference discusses the treatment of a pregnant woman with opioid use disorder in a comprehensive care program that includes buprenorphine pharmacotherapy. The presentation summarizes common experiences that pregnant women who receive buprenorphine pharmacotherapy face, and also what their prenatally opioid-exposed children confront in the immediate postpartum period. It describes the elements of a successful comprehensive care model and corollary neonatal abstinence syndrome treatment regimen. Expert commentary is included on issues that arise in the buprenorphine induction and maintenance throughout the prenatal and postpartum periods and in the treatment of co-occurring mental health problems during both the prenatal and postpartum periods, particularly the treatment of depression. There is also expert commentary on the care of opioid-exposed neonates, with attention to the treatment for neonatal abstinence syndrome.
BT - Journal of addiction medicine
C5 - Opioids & Substance Use; Healthcare Disparities
DO - 10.1097/ADM.0000000000000222
JF - Journal of addiction medicine
N2 - This clinical case conference discusses the treatment of a pregnant woman with opioid use disorder in a comprehensive care program that includes buprenorphine pharmacotherapy. The presentation summarizes common experiences that pregnant women who receive buprenorphine pharmacotherapy face, and also what their prenatally opioid-exposed children confront in the immediate postpartum period. It describes the elements of a successful comprehensive care model and corollary neonatal abstinence syndrome treatment regimen. Expert commentary is included on issues that arise in the buprenorphine induction and maintenance throughout the prenatal and postpartum periods and in the treatment of co-occurring mental health problems during both the prenatal and postpartum periods, particularly the treatment of depression. There is also expert commentary on the care of opioid-exposed neonates, with attention to the treatment for neonatal abstinence syndrome.
PY - 2016
SN - 1935-3227; 1932-0620
T1 - Neonatal Abstinence Syndrome: Presentation and Treatment Considerations
T2 - Journal of addiction medicine
TI - Neonatal Abstinence Syndrome: Presentation and Treatment Considerations
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 27244045
U3 - 10.1097/ADM.0000000000000222
VO - 1935-3227; 1932-0620
Y1 - 2016
ER -